Articles Referencing ACHN
Top 4 Insider Buys of Last Week
6/10/2013, 6:27 pm from GuruFocus in Investing
The following companies represent the most notable insider buys
of the past week. In order to be considered for this list, the
stock had to:
� Be in at least one guru's... Read >>
Why the Smart Money Is Bullish on Achillion Pharmaceuticals
5/31/2013, 2:35 pm from Minyanville in Investing, Options
Achillion Pharmaceuticals ( ACHN ) is a
biopharmaceutical company headquartered in New Haven, CT, and
specializing in the discovery, development, and commercialization
of treatments for... Read >>
Achillion's HCV Candidates Progress - Analyst Blog
4/17/2013, 5:12 pm from Zacks.com in Investing, Business, Stocks
Achillion Pharmaceuticals, Inc. ( ACHN ) recently
commenced international phase II studies on sovaprevir and ACH-3102
for the treatment of genotype 1 chronic hepatitis C (HCV). The
trial... Read >>
Mid-Afternoon Market Update: Markets Near Flat; J.C. Penney Falling Further
11/12/2012, 4:04 pm from Benzinga in Investing, Commodities, Earnings, Economy, International
Towards the end of trading Monday, the Dow traded up 0.05
percent to 12,821.30 while the NASDAQ fell 0.01 percent to
2,904.54. The S&P also rose, increasing 0.04 percent to
1,380.41. ... Read >>
Mid-Day Market Update: Markets Slow Their Rally; JC Penney Spikes Lower
11/12/2012, 12:49 pm from Benzinga in Investing, Commodities, Earnings, International, Investing Ideas
Following the market opening Monday, the Dow traded up 0.01
percent to 12,816.12 while the NASDAQ rose 0.07 percent to
2,906.84. The S&P also rose, increasing 0.04 percent to
1,380.41. ... Read >>
Top Ten Undervalued Stocks With Large Cash Cushions
11/21/2011, 9:16 pm from Kapitall in Investing, Investing Ideas, Business, Stocks
( Written by Rebecca Lipman. List compiled by Eben Esterhuizen, CFA. Operating expense and cash holdings data sourced from Google Finance, EPS data sourced from Yahoo! Finance.) Analyst target... Read >>
Biotech Update: Pharmasset’s Hepatitis C Drug Shows 100% Cure Rate in Ph2 Trial
11/9/2011, 8:18 pm from Kapitall in Investing, Investing Ideas, Stocks, Technology
( By Alexander Crawford ) The landscape of treatment options for hepatitis C is looking brighter – biotech company Pharmasset Inc ( VRUS ) just released clinical results showing that their... Read >>
Merck Reports Strong Q3 Results on Gardasil and Diabetes Med
11/6/2011, 8:19 pm from Kapitall in Investing, Investing Ideas, Stocks, Technology
(Written by Alexander Crawford. Institutional data sourced from Fidelity.) At a time of significant restructuring to adapt to generic competition, Merck & Co. ( MRK ) reported an otherwise... Read >>
10 Biotech Stocks Trading at Deep Discounts to Analyst Target Prices
10/31/2011, 9:18 pm from Kapitall in Investing, Investing Ideas, Stocks, Technology
(Written by Alexander Crawford. Target price data sourced from Thomson/First Call (via Yahoo! Finance)) Biotech companies deal with many uncertainties, and that directly translates to... Read >>
Top Performing Small Cap Stocks: July 7th (APAC, OCZ, BEBE, ACHN, HOTT)
7/8/2011, 11:00 am from Wyatt Investment Research in Investing, Stocks
Small cap stock indices climbed higher on Thursday, thanks to
news including an acquisition and better-than-expected results from
retailers and a rising star tech company.
But the... Read >>